SEC Form 4 · accession 0001209191-15-071986

ACORDA THERAPEUTICS INC · ACOR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Scientifc Officer

Period of report

Sep 21, 2015

Accepted (ET)

Sep 23, 2015 · 4:23 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001008848

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Sep 21, 2015	M	13,085	$6.00	A	84,744	D
Common Stock^F1,F2	Sep 21, 2015	S	6,894	$30.8451	D	77,850	D
Common Stock^F1,F3	Sep 21, 2015	S	6,191	$31.8149	D	71,659	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1,F4	$6.00	Sep 21, 2015	M	13,085	D	—	Feb 15, 2016	Common Stock	13,085	0	D

F1Exercise and sales pursuant to a 10b5-1 plan. Dr. Blight exercised 13,085 stock options, all of which were due to expire 2/15/2016 unless exercised.
F2The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $30.56 to $31.26 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.29 to $32.29 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4The shares subject to these options vested in installments and were fully vested on 2/15/2010.